Journey Medical (DERM) Other Non-Current Assets (2020 - 2024)
Journey Medical's (DERM) quarterly Other Non-Current Assets came in at $6000.0 in Q3 2024, little changed YoY from $6000.0 in Q4 2023, and little changed on a QoQ basis from $6000.0 in Q2 2024.
Journey Medical (DERM) Other Non-Current Assets (2020 - 2024) Analysis & Trends
Journey Medical (DERM) has 5 years of Other Non-Current Assets data on file, last reported at $6000.0 in Q3 2024.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $6000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $6000.0 (changed 0.0% YoY) and the FY2023 annual result came in at $6000.0, down 93.68% from the prior year.
- Other Non-Current Assets was little changed at $6000.0 in Q3 2024, from $6000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $749000.0 in Q3 2021 to a low of $6000.0 in Q4 2020.
- A 5-year average of $103928.6 and a median of $47000.0 in 2020 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets jumped 2400.0% — and 2023, when it slumped 94.55%.
- Tracing DERM's Other Non-Current Assets over 5 years: stood at $6000.0 in 2020, then jumped by 2400.0% to $150000.0 in 2021, then sank by 36.67% to $95000.0 in 2022, then tumbled by 93.68% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024.
- The last three Other Non-Current Assets figures came in at $6000.0 (Q3 2024), $6000.0 (Q2 2024), and $6000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Journey Medical | 208.68 Mn | 183.03 Mn | 12.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 150,000.00 |
| Sep 30, 2021 | 749,000.00 |
| Dec 31, 2020 | 6,000.00 |